Abrdn Life Sciences Investors (HQL) P/B ratio
Abrdn Life Sciences Investors (HQL) trades at 1.1× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (September 30, 2025) its P/B ratio was 0.9×. That is 0.6% higher than the 0.9× of fiscal 2024. Figures as of 18 Nov 2026, 12:06 UTC, from Yahoo Finance.
Key facts
- P/B ratio today
- 1.1×
- P/B ratio, fiscal 2025
- 0.9×
- Change on fiscal 2024
- +0.6%
- Highest on record
- 0.9×fiscal 2025
- Lowest on record
- 0.8×fiscal 2022
- Fiscal years on record
- 42022–2025
Figures as of . Statements from Yahoo Finance. Figures, not advice.
Abrdn Life Sciences Investors P/B ratio, in more detail
Today's figure is 13.6% above the fiscal 2025 year-end.
Across the 4 fiscal year-ends on record (2022–2025), the highest was 0.9× in fiscal 2025 and the lowest 0.8× in fiscal 2022. Today's P/B ratio is above every one of the 4 fiscal year-ends on record; their median is 0.9×.
P/B ratio at each fiscal year-end
The last point is today's figure; the others are fiscal year-ends.
Abrdn Life Sciences Investors P/B ratio, year by year
| Fiscal year | P/B ratio | Change | Year ended | Share price at year-end | Book value per share |
|---|---|---|---|---|---|
| Today | 1.1× | — | $17.62 | — | |
| 2025 | 0.9× | 0.6% up | $15.51 | $16.74 | |
| 2024 | 0.9× | 4.9% up | $15.08 | $16.38 | |
| 2023 | 0.9× | 4.1% up | $12.47 | $14.21 | |
| 2022 | 0.8× | — | $13.66 | $16.20 |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.
How to read it
It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.
Abrdn Life Sciences Investors, figure by figure
- Abrdn Life Sciences Investors market cap
- Abrdn Life Sciences Investors revenue
- Abrdn Life Sciences Investors earnings
- Abrdn Life Sciences Investors earnings per share (EPS)
- Abrdn Life Sciences Investors P/E ratio
- Abrdn Life Sciences Investors P/S ratio
- Abrdn Life Sciences Investors free cash flow
- Abrdn Life Sciences Investors operating margin
- Abrdn Life Sciences Investors dividend
- Abrdn Life Sciences Investors shares outstanding
- Abrdn Life Sciences Investors total debt
- Abrdn Life Sciences Investors cash on hand
- Abrdn Life Sciences Investors total assets
- Abrdn Life Sciences Investors return on equity (ROE)
- Abrdn Life Sciences Investors return on invested capital (ROIC)
Abrdn Life Sciences Investors (HQL) overview: price, valuation and scorecard
Abrdn Life Sciences Investors P/B ratio: questions and answers
What is Abrdn Life Sciences Investors's P/B ratio?
Abrdn Life Sciences Investors (HQL) trades at 1.1× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (September 30, 2025) its P/B ratio was 0.9×. That is 0.6% higher than the 0.9× of fiscal 2024.
Is Abrdn Life Sciences Investors's P/B ratio high or low compared with its own history?
Today's P/B ratio is above every one of the 4 fiscal year-ends on record; their median is 0.9×.
What are the highest and lowest P/B ratio figures on record for Abrdn Life Sciences Investors?
Across the 4 fiscal year-ends on record (2022–2025), the highest was 0.9× in fiscal 2025 and the lowest 0.8× in fiscal 2022.
How is Abrdn Life Sciences Investors's P/B ratio calculated?
The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B. For Abrdn Life Sciences Investors it is on record here for 4 fiscal years, 2022 to 2025.
Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.
Learn: P/B ratio
All stocks guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Piotroski F-score: the nine tests and what they show
The Piotroski F-score is a 0–9 count of simple accounting tests a company passes: four on profitability, three on debt, liquidity and share issuance, two on operating efficiency. Joseph Piotroski's 2000 paper found that among cheap, high book-to-market stocks, high scorers went on to beat low scorers. It is a screen of financial health, not a valuation.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Abrdn Life Sciences Investors (HQL) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/HQL/pb-ratio
Underlying data: Yahoo Finance.